BARTOLI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 652
NA - Nord America 625
AS - Asia 214
AF - Africa 9
OC - Oceania 1
SA - Sud America 1
Totale 1.502
Nazione #
US - Stati Uniti d'America 624
IT - Italia 162
RU - Federazione Russa 151
PL - Polonia 150
SE - Svezia 76
CN - Cina 70
HK - Hong Kong 66
IE - Irlanda 61
SG - Singapore 44
CH - Svizzera 15
FI - Finlandia 14
IN - India 13
DE - Germania 9
CI - Costa d'Avorio 8
UA - Ucraina 6
VN - Vietnam 6
GB - Regno Unito 5
JO - Giordania 5
TR - Turchia 5
KR - Corea 4
ES - Italia 2
AU - Australia 1
BR - Brasile 1
CA - Canada 1
GE - Georgia 1
RO - Romania 1
SC - Seychelles 1
Totale 1.502
Città #
Warsaw 150
Chandler 83
Fairfield 75
Dublin 61
Ashburn 58
Hong Kong 46
Woodbridge 41
Singapore 33
Wilmington 31
Houston 30
Cambridge 29
Seattle 29
Beijing 27
Florence 25
Princeton 20
Shanghai 20
Altamura 16
Bern 15
Buffalo 15
Lawrence 15
Boston 13
Jacksonville 12
Moscow 12
Rome 12
Ann Arbor 11
Milan 11
Mumbai 11
Naples 10
Kent 9
Abidjan 8
Boardman 6
Bologna 6
Medford 6
Pisa 6
Andover 5
Catania 5
Izmir 5
New York 5
Cagliari 4
Dong Ket 4
Santa Clara 4
Seoul 4
West Jordan 4
Turin 3
Barcelona 2
Bari 2
Baselga di Pinè 2
Caserta 2
Cohasset 2
Falls Church 2
Helsinki 2
Hillsboro 2
Ho Chi Minh City 2
Iesi 2
Lissone 2
Macherio 2
Mariano Comense 2
Nanjing 2
Norwalk 2
Pune 2
Saint Paul 2
San Diego 2
Sant'Anastasia 2
Sassari 2
Selargius 2
Shijiazhuang 2
Trento 2
Arona 1
Atlanta 1
Auburn Hills 1
Bucharest 1
Chicago 1
Guangzhou 1
Kilburn 1
Kunming 1
London 1
Los Angeles 1
Messina 1
Miami Beach 1
Montevarchi 1
Nuremberg 1
Salerno 1
San Mateo 1
San Pietro di Feletto 1
Shenyang 1
Sydney 1
Toronto 1
Verona 1
Washington 1
Xuzhou 1
Yubileyny 1
Zhengzhou 1
Totale 1.066
Nome #
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 202
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 121
Calcinosis in systemic sclerosis: subsets, distribution and complications 105
The safety of iloprost in systemic sclerosis in a real-life experience 97
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). 96
Transitional connective tissue diseases: description of four cases 91
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study. 89
Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. 86
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 77
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 59
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 56
Quantiferon (QFT) identifies latent tuberculosis (LTB) but does not help the evaluation of the efficacy of prophylaxis in inflammatory arthritides 54
Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA). 53
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 50
Treatment of ulcers in systemic sclerosis 43
FAS/FASL and TF/FVII Levels In Rheumatoid Arthritis Patients Treated With TNF Antagonists 42
Ultrasound detects occult entheseal involvement in early psoriatic arthritis independently of clinical features and psoriasis severity. 38
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 34
Persistence of remission after lengthening of golimumab in inflammatory joint diseases 30
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 30
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 30
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 28
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus 15
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 3
Totale 1.529
Categoria #
all - tutte 5.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020177 0 0 2 18 21 21 19 26 19 27 17 7
2020/2021137 11 6 10 22 10 16 5 8 12 14 12 11
2021/2022100 3 8 4 2 10 5 1 10 4 2 20 31
2022/2023319 33 64 15 26 14 52 39 11 29 5 13 18
2023/2024318 12 25 31 13 18 46 18 67 12 41 27 8
2024/2025257 51 130 76 0 0 0 0 0 0 0 0 0
Totale 1.529